Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additional hCG for Luteal Phase Support in IHH
NCT05569577Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2021
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human chorionic gonadotropin in idiopathic hypogonadotropic hypogonadism (IHH) (2 arms), sponsored by Fudan University. Primary endpoints: Clinical pregnancy rate at 7 weeks, Cumulative pregnancy rate at 12 weeks and 1 more. Started Jan 2021; status: recruiting.
02
Drugs
human chorionic gonadotropin
03
Conditions
idiopathic hypogonadotropic hypogonadism (IHH)
Beyond the preview
Go deeper on NCT05569577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05569577.